Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.

Br J Cancer · 2014 · PMC3960631 · PMID 24569467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

reached borderline significanceno p-value reported

Interaction between ER-negative tumour patients and the type of protocol (SIM vs EC-T) reached borderline significance, with a P -value of 0.099.

also in 370 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.